Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a mirror and mild zaps restore arm movement after stroke?

NCT ID NCT04913506

Symptom relief Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested whether adding neuromuscular electrical stimulation (NMES) to mirror therapy improves arm function in people with hemiplegia (one-sided paralysis). 42 participants were split into three groups: mirror therapy alone, NMES alone, or both combined. The goal was to see if the combo offered extra benefits for movement, daily activities, and pain.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
neuromuscular electrical stimulation (NMES) and mirror therapy
What this could lead to
If it works, this could point toward a better rehabilitation approach for regaining arm movement after stroke.
What could go wrong
This is a small, early-stage study with only 42 participants, so results may not apply to everyone. The therapy is also time-intensive and requires a practitioner.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

42 people

The number who actually took part.

Started

Jun 2021

Finished

Jan 2023

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subacute hemiplegia * Patients who can communicate well, are motivated enough and are willing to participate in the study * Patients' medical conditions are stable * Initiation of voluntary extension movement in the wrist (lower limit) Exclusion Criteria: * The presence of more than one previous cerebrovascular disease (except transient ischemic attack). * Presence of flaccid hemiplegia. * Presence of a previous neurological disease causing a decrease in strength in the affected extremity. * Presence of deformity due to a previous fracture, inflammatory arthropathy, etc. in the affected extremity. * Presence of more than grade 3 spasticity in upper extremity according to Modified Ashworth Scale * Use of cardiac pace maker * Presence of fatal cardiac arrhythmia * Presence of seizure history within 2 years.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemiplegia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hemiplegia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemiplegia Upper extremity dysfunction

Contacts and locations

Locations

  • Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi

    Bursa, 16320, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.